ZC45-0245 Screening compound: 1-{8-[(1-acetylpiperidin-4-yl)methyl]-4-(1,3-oxazol-2-yl)-2,8-diazaspiro[4.5]decan-2-yl}-2-phenylethan-1-one

ZC45-0245 Screening compound: 1-{8-[(1-acetylpiperidin-4-yl)methyl]-4-(1,3-oxazol-2-yl)-2,8-diazaspiro[4.5]decan-2-yl}-2-phenylethan-1-one
ZC45-0245 Screening compound: 1-{8-[(1-acetylpiperidin-4-yl)methyl]-4-(1,3-oxazol-2-yl)-2,8-diazaspiro[4.5]decan-2-yl}-2-phenylethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound ZC45-0245
1-{8-[(1-acetylpiperidin-4-yl)methyl]-4-(1,3-oxazol-2-yl)-2,8-diazaspiro[4.5]decan-2-yl}-2-phenylethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

ZC45-0245

Molecular Formula

C27H36N4O3 (C27 H36 N4 O3)

Compound Name

1-{8-[(1-acetylpiperidin-4-yl)methyl]-4-(1,3-oxazol-2-yl)-2,8-diazaspiro[4.5]decan-2-yl}-2-phenylethan-1-one

IUPAC name

1-{8-[(1-acetylpiperidin-4-yl)methyl]-4-(13-oxazol-2-yl)-28-diazaspiro[4.5]decan-2-yl}-2-phenylethan-1-one

SMILES

CC(N1CCC(CN(CC2)CCC2(CN(C2)C(Cc3ccccc3)=O)C2c2ncco2)CC1)=O

InChI

InChI=1S/C27H36N4O3/c1-21(32)30-12-7-23(8-13-30)18-29-14-9-27(10-15-29)20-31(19-24(27)26-28-11-16-34-26)25(33)17-22-5-3-2-4-6-22/h2-6,11,16,23-24H,7-10,12-15,17-20H2,1H3/t24-/m0/s1

InChI Key

ZCKZFYUMMOQZOU-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD31957658

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.61

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.405

Distribution Coefficient, logD

-0.085

Water Solubility, LogSw

-2.34

Polar Surface Area

54.982

Acid Dissociation Constant (pKa)

17.94

Base Dissociation Constant (pKb)

9.89

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

59.26

ZC45-0245 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Nervous system
  • Cardiovascular
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with ZC45-0245 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound ZC45-0245?
Check Price and Availability of ZC45-0245, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of ZC45-0245 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for ZC45-0245
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for ZC45-0245
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of ZC45-0245 available by request